IDEXX beats expectations on Q4 results, raises 2020 guidance

IDEXX Laboratories Inc. (Nasdaq: IDXX) on Friday posted better-than-expected fourth-quarter results and raised its 2020 outlook for revenue and earnings.

The Westbrook-based provider of veterinary diagnostics and water testing reported revenues of $605.4 million, up 10% from a year earlier on an organic and reported basis. That exceeds the $599.94 million Zacks Investment Research analysts’ consensus forecast.

The company posted earnings per diluted share of $1.04 on a reported basis, representing 6% growth over a year ago. That’s higher than the consensus forecast of 91 cents a share. Read more

Related Posts

Business Leaders: Deborah Bronk steers Bigelow Lab expansion to boost reach, programming

Deborah Bronk is president, CEO and a senior research scientist at Bigelow Laboratory for Ocean Sciences in East Boothbay, which will...

24 March 2025

UNE retains R2 Research status, reinforcing leadership in scientific advancement

The University of New England has retained its status as one of the country’s leading research universities with the recent release...

23 March 2025

Maine college students investigate health effects of forever chemicals

Two dozen Maine college students are investigating the public health effects of forever chemicals by using zebrafish as human stand-ins and...

21 March 2025